Cite
HARVARD Citation
Lau, S. et al. (2020). Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model. Journal for immunotherapy of cancer. 8 (2), p. . [Online].